Hanmi Pharm. Co., Ltd. has announced promising research results for its novel obesity treatment, HM17321. This groundbreaking ...

In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.

Only 13 states currently offer Medicaid coverage for GLP-1 drugs, but the number of prescriptions and overall spending has ...

The Indo US Bridging RARE Summit 2024 will spotlight the urgent need for cross-border collaborations to address disparities in rare disease treatment by bringing together patient advocates, clinicians ...

In 2021, the Government of India established Centres of Excellence (CoEs) under the National Policy for Rare Diseases to ...

A costly campaign to legalize recreational marijuana in Florida failed Tuesday and California voters took a step toward tough crime laws as voters in dozens of states weighed more than 140 measures ...

This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 ...

I am a 69-year-old female. Recently, I had some blood work done, and my doctor put me on Lipitor based on my LDL results. After reading the side ...

As AFM attendees settle into their new Las Vegas home,Screen profiles a selection of key titles, at various stages of ...

Worldwide revenue of $378.7 million, an increase of 18.4% from third quarter 2023; GAAP fully diluted earnings per share of $1.79, compared to $1.88 in the third quarter of 2023.

Two Chicago health centers and a downstate hospital system are learning how to be both provider and payor to mostly dual-eligible elderly patients through PACE.